Revathi Suppiah

Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma.

Gordan Srkalovic, Esteban Walker, Eric Hsi, 2006, Mayo Clinic proceedings.

Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)

P. Elson, L. Wood, G. Budd, 2005, Investigational New Drugs.